BFRG

BullFrog AI Holdings, Inc.

Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0001829247 Biotech & Drug Discovery

$0.4810 −0.01 (−2.63%)

Oct 26 4:00 PM ET · prev $0.4940

Market cap

$9.1M

Nano cap

Next earnings

Nov 12

in 16 days · EPS est. −$0.09

1 year

−65.4%

from $1.39 · Oct 27

30 days

−26.8%

from $0.6570

52-week range

$0.4290–1.68

−71% from high · low Sep 16

Avg volume 20D

3.48M

Oct 6 spike 37.77M

Short interest

🔒 Subscribers only

Insider net

+$71.3K

2 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 1 report · 90 days

Balance 1 bearish · 0 bullish oldest → newest, height = score

Avg score

·High conf. 1/1 ·Next Earnings date, Nov 12, 2026

Strongest BEARISH BullFrog AI Holdings received a second 180-day compliance period from Nasdaq, extending the deadline to…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

E Jan 9 FDA decision: PDUFA: BFRG — Unknown in Unknown — 2026-01-09
R Apr 13 BullFrog AI announced a commercial feasibility agreement with a top…
R Aug 20 BullFrog AI Holdings received a second 180-day compliance period fro…
B Sep 22 2 insiders buy $71.3K at $0.5707
X Sep 30 Short interest jumps 626.5% to 739.2K

Signal stack

Where each data set points today.

InsidersBULLISH

2 insiders bought $71.3K at an average $0.5707. No open-market sales. Price is 16% below their cost.
InstitutionsBULLISH

Q2 2026: 4 added (0 new), 1 trimmed or exited.
TrendDOWNTREND

14% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
VANGUARD FIDUCIARY TRUST CO	DOUBLED	106,484	$75.6K
GEODE CAPITAL MANAGEMENT, LLC	ADD	104,928	$74.5K
Vontobel Holding Ltd.	ADD	70,000	$49.7K
RAYMOND JAMES FINANCIAL INC	DOUBLED	44,411	$31.5K
UBS Group AG	NEAR_EXIT	7	$5.00
GEODE CAPITAL MANAGEMENT, LLC	ADD	72,715	$64.2K
UBS Group AG	DOUBLED	15,170	$13.4K
UBS Group AG	DOUBLED	7,095	$9.9K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 12, 2026

Earnings date

BFRG Q3 2026 Earnings Scheduled — 2026-11-12

Recent

Oct 15, 2026

Short interest

🔒 Fresh data, subscribers only

Oct 6, 2026

Press release

BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder

Achieves key commercial project milestones utilizing its proprietary artificial intelligence (“AI”) and machine learning platform to identify and…

Sep 8, 2026

Press release

BullFrog AI to Participate in September 2026 Investor Conferences

GAITHERSBURG, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI…

Aug 11, 2026

Earnings date

BFRG Q2 2026 Earnings Scheduled — 2026-08-11

Apr 22, 2026

Press release

BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement

Strengthened balance sheet provides capital runway into late 2027 Strengthened balance sheet provides capital runway into late 2027

Insider ledger

Form 4

$71.3K

bought · 2 insiders

sold · 0 insiders

−15.7%

vs their $0.5707 cost

Date	Insider	Type	Value
Sep 22, 2026	Singh Vininder Chief Executive Officer	BUY	$44.9K
Sep 22, 2026	Blacher Joshua Chief Financial Officer	BUY	$26.4K
Jun 11, 2026	Hanson Jason David Director	AWARD	15,000 sh
Jun 11, 2026	Enright William Director	AWARD	15,000 sh
Jun 11, 2026	Elsey R Don Director	AWARD	15,000 sh

Earnings setup

Estimates

Nov 12

reports in 16 days

−$0.09

EPS estimate, this quarter

1↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

−$0.110

30d

−$0.110

−$0.090

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.09	-$0.09–-$0.09	+18.2%	$215.0K
Next Q	-$0.10	-$0.10–-$0.10	+0.0%	$350.0K
Current FY	-$0.37	-$0.37–-$0.37	+15.9%	$780.0K
Next FY	-$0.17	-$0.17–-$0.17	+19.0%	$5.3M